JIE Guang-ling, NIU Xiao-min. Orient-31 Model Discussion: Immunotherapy Can Be Used After Drug Resistance of Advanced NSCLC With Oncogenic Driver Mutation[J]. Journal of Evidence-Based Medicine. DOI: 10.12019/j.issn.1671-5144.202402008
    Citation: JIE Guang-ling, NIU Xiao-min. Orient-31 Model Discussion: Immunotherapy Can Be Used After Drug Resistance of Advanced NSCLC With Oncogenic Driver Mutation[J]. Journal of Evidence-Based Medicine. DOI: 10.12019/j.issn.1671-5144.202402008

    Orient-31 Model Discussion: Immunotherapy Can Be Used After Drug Resistance of Advanced NSCLC With Oncogenic Driver Mutation

    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return